FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100717844> ?p ?o ?g. }

• W2100717844 endingPage "1332" @default.
• W2100717844 startingPage "1325" @default.
• W2100717844 abstract "Excessive proliferation of vascular smooth muscle cells (VSMCs) and neointimal formation are critical steps in the pathogenesis of atherosclerosis and restenosis after percutaneous transluminal angioplasty. In this study, we investigated the hypothesis that the activator protein-1 (AP-1) plays an important role in neointimal formation after vascular injury. A circular dumbbell AP-1 decoy oligodeoxynucleotide (CDODN) was developed as a novel therapeutic strategy for restenosis after angioplasty. This CDODN was more stable than the conventional phosphorothioate linear decoy ODN (PSODN) and maintained structural integrity on exposure to exonuclease III or serum. Transfection with AP-1 decoy ODNs strongly inhibited VSMC proliferation and migration, as well as glucose- and serum-induced expression of PCNA and cyclin A genes. Administration of AP-1 decoy ODNs in vivo using the hemagglutinating virus of Japan (HVJ)-liposome method virtually abolished neointimal formation after balloon injury to the rat carotid artery. Compared with PSODN, CDODN was more effective in inhibiting the proliferation of VSMCs in vitro and neointimal formation in vivo. Our results collectively indicate that AP-1 activation is crucial for the mediation of VSMC proliferation in response to vascular injury. Moreover, the use of stable CDODN specific for AP-1 activity in combination with the highly effective HVJ-liposome method provides a novel potential therapeutic strategy for the prevention of restenosis after angioplasty in humans." @default.
• W2100717844 created "2016-06-24" @default.
• W2100717844 creator A5011504123 @default.
• W2100717844 creator A5025005882 @default.
• W2100717844 creator A5034271311 @default.
• W2100717844 creator A5035690766 @default.
• W2100717844 creator A5036375305 @default.
• W2100717844 creator A5043625041 @default.
• W2100717844 creator A5047744517 @default.
• W2100717844 creator A5048235248 @default.
• W2100717844 creator A5055267059 @default.
• W2100717844 creator A5063905870 @default.
• W2100717844 creator A5069415228 @default.
• W2100717844 creator A5069695007 @default.
• W2100717844 creator A5091657288 @default.
• W2100717844 date "2002-06-28" @default.
• W2100717844 modified "2023-10-06" @default.
• W2100717844 title "Inhibitory Effects of Novel AP-1 Decoy Oligodeoxynucleotides on Vascular Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo" @default.
• W2100717844 cites W1496645167 @default.
• W2100717844 cites W1985288394 @default.
• W2100717844 cites W1988460287 @default.
• W2100717844 cites W2009334399 @default.
• W2100717844 cites W2027835440 @default.
• W2100717844 cites W2031272027 @default.
• W2100717844 cites W2032223601 @default.
• W2100717844 cites W2034487226 @default.
• W2100717844 cites W2044695819 @default.
• W2100717844 cites W2053673451 @default.
• W2100717844 cites W2067182112 @default.
• W2100717844 cites W2076029740 @default.
• W2100717844 cites W2082301173 @default.
• W2100717844 cites W2085641706 @default.
• W2100717844 cites W2093925810 @default.
• W2100717844 cites W2110469741 @default.
• W2100717844 cites W2118897660 @default.
• W2100717844 cites W2146354013 @default.
• W2100717844 cites W2413240181 @default.
• W2100717844 doi "https://doi.org/10.1161/01.res.0000023200.19316.d5" @default.
• W2100717844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12089071" @default.
• W2100717844 hasPublicationYear "2002" @default.
• W2100717844 type Work @default.
• W2100717844 sameAs 2100717844 @default.
• W2100717844 citedByCount "110" @default.
• W2100717844 countsByYear W21007178442012 @default.
• W2100717844 countsByYear W21007178442013 @default.
• W2100717844 countsByYear W21007178442014 @default.
• W2100717844 countsByYear W21007178442015 @default.
• W2100717844 countsByYear W21007178442016 @default.
• W2100717844 countsByYear W21007178442017 @default.
• W2100717844 countsByYear W21007178442018 @default.
• W2100717844 countsByYear W21007178442019 @default.
• W2100717844 countsByYear W21007178442021 @default.
• W2100717844 countsByYear W21007178442022 @default.
• W2100717844 countsByYear W21007178442023 @default.
• W2100717844 crossrefType "journal-article" @default.
• W2100717844 hasAuthorship W2100717844A5011504123 @default.
• W2100717844 hasAuthorship W2100717844A5025005882 @default.
• W2100717844 hasAuthorship W2100717844A5034271311 @default.
• W2100717844 hasAuthorship W2100717844A5035690766 @default.
• W2100717844 hasAuthorship W2100717844A5036375305 @default.
• W2100717844 hasAuthorship W2100717844A5043625041 @default.
• W2100717844 hasAuthorship W2100717844A5047744517 @default.
• W2100717844 hasAuthorship W2100717844A5048235248 @default.
• W2100717844 hasAuthorship W2100717844A5055267059 @default.
• W2100717844 hasAuthorship W2100717844A5063905870 @default.
• W2100717844 hasAuthorship W2100717844A5069415228 @default.
• W2100717844 hasAuthorship W2100717844A5069695007 @default.
• W2100717844 hasAuthorship W2100717844A5091657288 @default.
• W2100717844 hasBestOaLocation W21007178442 @default.
• W2100717844 hasConcept C126322002 @default.
• W2100717844 hasConcept C150903083 @default.
• W2100717844 hasConcept C170493617 @default.
• W2100717844 hasConcept C202751555 @default.
• W2100717844 hasConcept C207001950 @default.
• W2100717844 hasConcept C2777339539 @default.
• W2100717844 hasConcept C2778095995 @default.
• W2100717844 hasConcept C2778283817 @default.
• W2100717844 hasConcept C2778583881 @default.
• W2100717844 hasConcept C2779179475 @default.
• W2100717844 hasConcept C2779395532 @default.
• W2100717844 hasConcept C2992686903 @default.
• W2100717844 hasConcept C502942594 @default.
• W2100717844 hasConcept C54009773 @default.
• W2100717844 hasConcept C54355233 @default.
• W2100717844 hasConcept C55493867 @default.
• W2100717844 hasConcept C62112901 @default.
• W2100717844 hasConcept C71924100 @default.
• W2100717844 hasConcept C81885089 @default.
• W2100717844 hasConcept C86803240 @default.
• W2100717844 hasConcept C98274493 @default.
• W2100717844 hasConceptScore W2100717844C126322002 @default.
• W2100717844 hasConceptScore W2100717844C150903083 @default.
• W2100717844 hasConceptScore W2100717844C170493617 @default.
• W2100717844 hasConceptScore W2100717844C202751555 @default.
• W2100717844 hasConceptScore W2100717844C207001950 @default.
• W2100717844 hasConceptScore W2100717844C2777339539 @default.
• W2100717844 hasConceptScore W2100717844C2778095995 @default.
• W2100717844 hasConceptScore W2100717844C2778283817 @default.

• next